Frank Yocca - Chief Scientific Officer at BioXcel Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Scientific Officer
Issuer Symbol
BTAI on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Frank Yocca since 07 Feb 2025

Holdings reported by Frank Yocca for BioXcel Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 6,452 $13,420 $2.08 15 Dec 2025 Direct
Restricted Stock Units 70,282 $136 $0.3523 01 Jan 2026 Direct Common Stock
Stock Option (right to buy) 270,000 07 Jan 2025 Direct Common Stock

Transactions reported by Frank Yocca for BioXcel Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.